TI
ORGS

Trexquant Investment’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Trexquant Investment’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,102
Closed -$107K – 1569
2021
Q2 		$107K Buy
+2,102
New +$106K 0.01% 1012

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Trexquant Investment's ORGS Position: Q3 2021 in Review

Trexquant Investment sold out of Orgenesis Inc. Common Stock (ORGS) in Q3 2021, closing a stake of 2,102 shares — an estimated $107K sold.

Trexquant Investment first reported a position in ORGS in Q2 2021 and held it in 1 quarter. The position peaked at $107K in Q2 2021. 26 funds tracked by Wall St. Rank hold ORGS as of Q3 2021.

  • Trexquant Investment reported no remaining Orgenesis Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Trexquant Investment sold 2,102 Orgenesis Inc. Common Stock shares in Q3 2021, an estimated $107K.
  • Trexquant Investment first reported a position in Orgenesis Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Trexquant Investment's Orgenesis Inc. Common Stock position peaked at $107K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q3 2021.

Based on Trexquant Investment's 13F filing for Q3 2021, filed 12 Nov 2021.